CRDF Stock-Based Compensation
Cardiff Oncology Inc · Stock-Based Compensation
CRDF Stock-Based Compensation
Latest reported$5.23Mperiod ending
CRDF TTM Stock-Based Comp ($0.00 → $5.23M)
TTM stock-based compensation
High-resolution chart · PNG
CRDF stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,225,000 | |
| 5,988,000 | |
| 5,693,000 | |
| 5,636,000 | |
| 5,505,000 | |
| 5,001,000 | |
| 4,760,000 | |
| 4,465,000 | |
| 4,167,000 | |
| 4,569,000 | |
| 4,509,000 | |
| 4,612,000 | |
| 4,694,000 | |
| 4,168,000 | |
| 4,256,000 | |
| 4,234,000 | |
| 4,137,000 | |
| 4,118,000 | |
| 3,234,000 | |
| 3,187,835 | |
| 2,247,835 | |
| 1,211,835 | |
| 1,120,835 | |
| 446,717 | |
| 713,042 | |
| 862,042 | |
| 885,042 | |
| 884,300 | |
| 896,196 | |
| 968,496 | |
| 2,174,627 | |
| 2,800,873 | |
| 3,943,832 | |
| 4,497,917 | |
| 4,012,585 | |
| 4,679,288 | |
| 5,087,479 | |
| 5,614,007 | |
| 7,504,316 | |
| 7,129,572 | |
| 6,223,861 | |
| 6,045,394 | |
| 3,946,027 | |
| 3,444,082 | |
| 2,926,121 | |
| 2,222,162 | |
| 2,070,194 | |
| 1,507,639 | |
| 2,071,016 | |
| 1,998,871 | |
| 1,979,364 | |
| 2,039,814 | |
| 1,201,098 | |
| 969,576 | |
| 532,140 | |
| 396,313 | |
| 348,923 | |
| 289,648 | |
| 250,978 | |
| 203,675 | |
| 120,705 | |
| 64,160 | |
| 2,006 | |
| 4,012 | |
| 559,671 | |
| 4,150,301 | |
| 4,148,295 | |
| 4,146,289 | |
| 3,590,630 | |
| 0 |